Bard Peripheral Vascular, Inc.: FDA filings under this applicant name
FDA lists 39 510(k) clearances under 2 spellings of the applicant name “Bard Peripheral Vascular, Inc.” (first 2003, latest 2026), plus 7 PMA decisions, across 22 product codes in 5 review panels. Median 510(k) review time under this name: 41 days. Since 2017 the median was 84 days, against 108 days for all cleared 510(k)s in the same product codes. Related companies, subsidiaries and acquired businesses that file under other applicant names are counted on their own pages, not here.
Caduvo groups this applicant name under BD (Becton, Dickinson and Company), based on public ownership records.
510(k) clearances per year
| Year | Clearances | Median review days |
|---|---|---|
| 2012 | 3 | 17 |
| 2013 | 2 | 32 |
| 2014 | 2 | 50 |
| 2015 | 0 | — |
| 2016 | 2 | 135 |
| 2017 | 2 | 134 |
| 2018 | 1 | 60 |
| 2019 | 2 | 29 |
| 2020 | 0 | — |
| 2021 | 2 | 26 |
| 2022 | 2 | 60 |
| 2023 | 1 | 92 |
| 2024 | 1 | 156 |
| 2025 | 5 | 140 |
| 2026 | 2 | 26 |
Review time against the same product codes
Since 2017, 510(k)s cleared under the name Bard Peripheral Vascular, Inc. took a median 84 days from FDA receipt to decision. All cleared 510(k)s in the same product codes over the same years took a median 108 days.
Top product codes
| Product code | Device | Submissions | 510(k) clearances |
|---|---|---|---|
| KNW | Instrument, Biopsy | 8 | 8 |
| LIT | Catheter, Angioplasty, Peripheral, Transluminal | 6 | 6 |
| DQY | Catheter, Percutaneous | 5 | 5 |
| NEU | Marker, Radiographic, Implantable | 3 | 3 |
| DSY | Prosthesis, Vascular Graft, Of 6mm And Greater Diameter | 2 | 2 |
| DTK | Filter, Intravascular, Cardiovascular | 2 | 2 |
| FGE | Stents, Drains And Dilators For The Biliary Ducts | 2 | 2 |
| JCT | Prosthesis, Tracheal, Expandable | 2 | 2 |
| PFV | System, Endovascular Graft, Arteriovenous (Av) Dialysis Access Circuit Stenosis Treatment | 2 | 0 |
| PNO | Catheter, Percutaneous, Cutting/Scoring | 2 | 2 |
Plus 12 more product codes.
Review panels
- Cardiovascular (27)
- General and Plastic Surgery (11)
- Gastroenterology and Urology (4)
- Anesthesiology (2)
- General Hospital (2)
Most recent Bard Peripheral Vascular, Inc. 510(k) clearances
| 510(k) | Device | Product code | Decision date | Review days |
|---|---|---|---|---|
| K262571 | EnCor EnCompass Breast Biopsy and Tissue Removal System | KNW | 2026-08-14 | 21 |
| K260012 | UltraScore Focused Force PTA Balloon | PNO | 2026-02-04 | 30 |
| K252681 | EnCor EnCompass Breast Biopsy and Tissue Removal System | KNW | 2025-12-12 | 109 |
| K250032 | Marquee Disposable Core Biopsy Instrument and Instrument Kit | KNW | 2025-07-10 | 184 |
| K250219 | Dorado PTA Balloon Dilatation Catheter | DQY | 2025-06-17 | 144 |
| K243642 | UltraCor Twirl Breast Tissue Marker | NEU | 2025-03-24 | 118 |
| K242757 | Rotarex Atherectomy System | MCW | 2025-01-30 | 140 |
| K241946 | PeritX 1L Drainage Kit (90-1010); PeritX 2L Drainage Kit (90-2010); PeritX Peritoneal Catheter Kit (50-9000C); PeritX Peritoneal Catheter and Starter Kit (50-9900C); PeritX Peritoneal Catheter Mini Kit (50-9050A); PleurX Low Profile Catheter Mini Kit (50-8050); Valve Cap (50-7235A); PeritX Valve Kit (50-7272); Catheter Access Kit (50-7280A); Lockable Drainage Line (50-7245A); Lockable Drainage Line Kit (50-7265A); PleurX Supplemental Insertion Kit (50-7262); Procedure Pack (50- | PNG | 2024-12-06 | 156 |
| K232737 | PowerPort ClearVUE Slim ECG Enabled Implantable Port; PowerPort ClearVUE isp ECG Enabled Implantable Port; PowerPort isp M.R.I. ECG Enabled Implantable Port; PowerPort Slim ECG Enabled Implantable Port | LJT | 2023-12-08 | 92 |
| K221440 | Liverty TIPS Access Set | DYB | 2022-05-31 | 14 |
29 earlier clearances. See the full list in Caduvo.
PMA and De Novo decisions
| Number | Pathway | Device | Decision date |
|---|---|---|---|
| P250050 | PMA | Liverty TIPS Stent Graft | 2026-09-25 |
| P180037 | PMA | Venovo Venous Stent System | 2019-03-13 |
| P160024 | PMA | LIFESTREAM BALLOON EXPANDABLE VASCULAR COVERED STENT | 2017-04-24 |
| P130029 | PMA | FLUENCY PLUS ENDOVASCULAR STENT GRAFT | 2014-06-17 |
| P070014 | PMA | LIFESTENT FLEXSTAR & FLEXSTAR XL VASCULAR STENT SYSTEM | 2009-02-13 |
Recalls
237 product recalls in 69 recall events; 28 initiated in the last five years. Most recent: 2026-08-20.
Recalling firms are matched to this applicant name by name only (same normalization), so related entities that recall under another name are not counted. A recall count says nothing about how safe one company's devices are compared with another's.
Parent company SEC filings
BECTON DICKINSON & CO (BDX): EDGAR filings, CIK 10795. Caduvo groups Bard Peripheral Vascular, Inc. under BD (Becton, Dickinson and Company); the parent's SEC registrant is entered by hand for the group, not matched by name.
FDA spellings included
FDA records this applicant under 2 spellings (case, punctuation and legal-suffix variants of one name); this page adds them up. Filings per spelling:
- Bard Peripheral Vascular, Inc. (41)
- Bard Peripheral Vascular (5)
Other FDA applicant names starting with the same word
FDA records these as separate applicants. Some may belong to the same corporate group and some may not; their filings are not included in the counts above.
- Bard Access Systems, Inc. (22 510(k)s)
- Bard Access Systems, Inc. (C.R. Bard, Inc.) (3 510(k)s)
- Bard Cardiosurgery Div (3 510(k)s)
- Bard Diagnostic Sciences,Inc. (3 510(k)s)
- Bard Electrophysiology (3 510(k)s)
- Bard Medical Div. (3 510(k)s)
- Bard Access Systems, Inc. (Bard Has Joined Bd) (2 510(k)s)
- Bard Interventional Products Div. (2 510(k)s)
- Bard Access Systems, Inc(Bas)[Wholly-Owned Subsidiary of Bd] (1 510(k)s)
- Bard Electro Medical Systems, Inc. (1 510(k)s)
- Bard Gynecology and Radiology (1 510(k)s)
- Bard Medsystems Div. (1 510(k)s)
Frequently asked questions
How many FDA 510(k) clearances are listed under Bard Peripheral Vascular, Inc.?
FDA lists 39 510(k) clearances under 2 spellings of the applicant name “Bard Peripheral Vascular, Inc.” (first 2003, latest 2026), plus 7 PMA decisions, across 22 product codes in 5 review panels. Filings under other applicant names, such as subsidiaries, are not included.
How long has FDA taken to clear 510(k)s filed by Bard Peripheral Vascular, Inc.?
The median time from FDA receipt to decision across 510(k)s cleared under the name Bard Peripheral Vascular, Inc. is 41 days. Since 2017: 84 days, versus 108 days for all cleared 510(k)s in the same product codes.
Which FDA product codes appear under Bard Peripheral Vascular, Inc.?
The most frequent FDA product codes under this applicant name are KNW (Instrument, Biopsy, 8); LIT (Catheter, Angioplasty, Peripheral, Transluminal, 6); DQY (Catheter, Percutaneous, 5).
Next steps
- See all 39 Bard Peripheral Vascular, Inc. clearances with predicates and recalls
- Run predicate analysis for product code KNW, Bard Peripheral Vascular, Inc.'s most frequent
Compiled by Caduvo from public U.S. government records. Counts cover filings under the applicant names shown on this page only. Review days run from FDA receipt to decision. Not reviewed or endorsed by FDA or any other agency, or by the companies named. Not regulatory advice. Report an error in this data. Data and corrections policy.